164 related articles for article (PubMed ID: 10447750)
1. FcepsilonRI-mediated antigen endocytosis turns interferon-gamma-treated mouse mast cells from inefficient into potent antigen-presenting cells.
Tkaczyk C; Villa I; Peronet R; David B; Mécheri S
Immunology; 1999 Jun; 97(2):333-40. PubMed ID: 10447750
[TBL] [Abstract][Full Text] [Related]
2. The antigen presentation function of bone marrow-derived mast cells is spatiotemporally restricted to a subset expressing high levels of cell surface FcepsilonRI and MHC II.
Gong J; Yang NS; Croft M; Weng IC; Sun L; Liu FT; Chen SS
BMC Immunol; 2010 Jun; 11():34. PubMed ID: 20591187
[TBL] [Abstract][Full Text] [Related]
3. Presentation of soluble antigens by mast cells: upregulation by interleukin-4 and granulocyte/macrophage colony-stimulating factor and downregulation by interferon-gamma.
Frandji P; Tkaczyk C; Oskéritzian C; Lapeyre J; Peronet R; David B; Guillet JG; Mécheri S
Cell Immunol; 1995 Jun; 163(1):37-46. PubMed ID: 7758129
[TBL] [Abstract][Full Text] [Related]
4. Exogenous and endogenous antigens are differentially presented by mast cells to CD4+ T lymphocytes.
Frandji P; Tkaczyk C; Oskeritzian C; David B; Desaymard C; Mécheri S
Eur J Immunol; 1996 Oct; 26(10):2517-28. PubMed ID: 8898968
[TBL] [Abstract][Full Text] [Related]
5. Specific antigen targeting to surface IgE and IgG on mouse bone marrow-derived mast cells enhances efficiency of antigen presentation.
Tkaczyk C; Viguier M; Boutin Y; Frandji P; David B; Hébert J; Mécheri S
Immunology; 1998 Jul; 94(3):318-24. PubMed ID: 9767412
[TBL] [Abstract][Full Text] [Related]
6. Resveratrol Suppresses Cytokine Production Linked to FcεRI-MAPK Activation in IgE-Antigen Complex-Exposed Basophilic Mast Cells and Mice.
Han SY; Choi YJ; Kang MK; Park JH; Kang YH
Am J Chin Med; 2015; 43(8):1605-23. PubMed ID: 26621445
[TBL] [Abstract][Full Text] [Related]
7. IL-4 mRNA transcription is induced in mouse bone marrow-derived mast cells through an MHC class II-dependent signaling pathway.
Frandji P; Mourad W; Tkaczyk C; Singer M; David B; Colle JH; Mécheri S
Eur J Immunol; 1998 Mar; 28(3):844-54. PubMed ID: 9541579
[TBL] [Abstract][Full Text] [Related]
8. Capacity of mouse mast cells to prime T cells and to induce specific antibody responses in vivo.
Villa I; Skokos D; Tkaczyk C; Peronet R; David B; Huerre M; Mécheri S
Immunology; 2001 Feb; 102(2):165-72. PubMed ID: 11260321
[TBL] [Abstract][Full Text] [Related]
9. Role of the FcepsilonRI beta-chain ITAM as a signal regulator for mast cell activation with monomeric IgE.
Nunomura S; Gon Y; Yoshimaru T; Suzuki Y; Nishimoto H; Kawakami T; Ra C
Int Immunol; 2005 Jun; 17(6):685-94. PubMed ID: 15944196
[TBL] [Abstract][Full Text] [Related]
10. FcepsilonRI-alpha siRNA inhibits the antigen-induced activation of mast cells.
Safaralizadeh R; Soheili ZS; Deezagi A; Pourpak Z; Samiei S; Moin M
Iran J Allergy Asthma Immunol; 2009 Dec; 8(4):177-83. PubMed ID: 20404387
[TBL] [Abstract][Full Text] [Related]
11. Insulin potentiates FcepsilonRI-mediated signaling in mouse bone marrow-derived mast cells.
Kettner A; Di Matteo M; Santoni A
Mol Immunol; 2010 Feb; 47(5):1039-46. PubMed ID: 20004975
[TBL] [Abstract][Full Text] [Related]
12. Protein tyrosine phosphatase epsilon is a negative regulator of FcepsilonRI-mediated mast cell responses.
Akimoto M; Mishra K; Lim KT; Tani N; Hisanaga SI; Katagiri T; Elson A; Mizuno K; Yakura H
Scand J Immunol; 2009 May; 69(5):401-11. PubMed ID: 19508371
[TBL] [Abstract][Full Text] [Related]
13. Histamine receptor H4 regulates mast cell degranulation and IgE induced FcεRI upregulation in murine bone marrow-derived mast cells.
Mirzahosseini A; Dalmadi B; Csutora P
Cell Immunol; 2013; 283(1-2):38-44. PubMed ID: 23850674
[TBL] [Abstract][Full Text] [Related]
14. Granulocyte-macrophage colony-stimulating factor activates macrophages derived from bone marrow cultures to synthesis of MHC class II molecules and to augmented antigen presentation function.
Fischer HG; Frosch S; Reske K; Reske-Kunz AB
J Immunol; 1988 Dec; 141(11):3882-8. PubMed ID: 3141506
[TBL] [Abstract][Full Text] [Related]
15. Abrogation of high-affinity IgE receptor-mediated mast cell activation at the effector phase prevents contact hypersensitivity to oxazolone.
Kobayashi M; Nunomura S; Gon Y; Endo D; Kishiro S; Fukunaga M; Kitahata Y; Terui T; Ra C
J Invest Dermatol; 2010 Mar; 130(3):725-31. PubMed ID: 19741711
[TBL] [Abstract][Full Text] [Related]
16. Indirect involvement of allergen-captured mast cells in antigen presentation.
Kambayashi T; Baranski JD; Baker RG; Zou T; Allenspach EJ; Shoag JE; Jones PL; Koretzky GA
Blood; 2008 Feb; 111(3):1489-96. PubMed ID: 18032707
[TBL] [Abstract][Full Text] [Related]
17. IL-33 induces IL-13 production by mouse mast cells independently of IgE-FcepsilonRI signals.
Ho LH; Ohno T; Oboki K; Kajiwara N; Suto H; Iikura M; Okayama Y; Akira S; Saito H; Galli SJ; Nakae S
J Leukoc Biol; 2007 Dec; 82(6):1481-90. PubMed ID: 17881510
[TBL] [Abstract][Full Text] [Related]
18. C3a-derived peptide binds to the type I FcepsilonR and inhibits proximal-coupling signal processes and cytokine secretion by mast cells.
Péterfy H; Tóth G; Pecht I; Erdei A
Int Immunol; 2008 Oct; 20(10):1239-45. PubMed ID: 18653698
[TBL] [Abstract][Full Text] [Related]
19. The scaffold protein prohibitin is required for antigen-stimulated signaling in mast cells.
Kim DK; Kim HS; Kim AR; Jang GH; Kim HW; Park YH; Kim B; Park YM; Beaven MA; Kim YM; Choi WS
Sci Signal; 2013 Sep; 6(292):ra80. PubMed ID: 24023254
[TBL] [Abstract][Full Text] [Related]
20. Granulocyte-macrophage colony-stimulating factor-cultured bone marrow-derived macrophages reveal accessory cell function and synthesis of MHC class II determinants in the absence of external stimuli.
Fischer HG; Opel B; Reske K; Reske-Kunz AB
Eur J Immunol; 1988 Aug; 18(8):1151-8. PubMed ID: 3138135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
